Partnership Opportunities
Looking to Partner with the World CNS Series?
Following a year of significant pharma acquisitions, approvals of transformative drugs the first of their kind, and a surge of financial backing to bolster innovation in new targets and preclinical pipelines, 2026 is set to continue this momentum, with more companies prioritizing neuroscience drug development than ever before.
If you have relevant capabilities in this space and would like to align your brand with the CNS community, contact us to promote your capabilities through a bespoke commercial package.
Your Targeted, High-Impact Platform to Engage Prospective & Existing Clients That Are at the Forefront of CNS Biomarker Innovation
Positioned at the forefront of CNS biomarker innovation, the 3rd Fluid & Imaging Biomarkers in Neuroscience Summit is the only industry-focused forum, dedicated exclusively to advancing the discovery, validation and clinical application of enhanced biomarker technologies for neurodegenerative and neuroinflammatory diseases.
Unlike broader meetings, this summit unites a niche yet highly influential audience actively seeking next-generation solutions in assay development, multi-omics integration, and scalable diagnostic technologies. As a partner, you can gain direct access to key biotech and pharma decision makers discussing their most pressing translational and clinical pain points. If you are looking to increase brand awareness, showcase your unique offerings to the CNS industry and be the go-to solution provider for biomarker and diagnostic capabilities, this is your unrivalled opportunity.
Why Partner?
Showcase your cutting-edge solutions to a curated audience of decision-makers spanning preclinical, translational, and clinical neuroscience development.
Build brand credibility and visibility as a commercial ally for CNS biopharma teams in need of innovative diagnostic tools, precision imaging platforms, and scalable therapeutic monitoring platforms
Gain insider insight into the core challenges facing biopharma to tailor, refine, and deliver standout solutions that truly resonate
Leverage targeted networking opportunities to connect with emerging neuroscience companies actively seeking partnerships to scale their biomarker strategies
Key Interest Areas
New and improved assay development and validation to enhance accuracy, credibility, and clinical relevance
Highly specific, sensitive and reliable omics platforms to enable comprehensive analysis and reproducibility
Clinically scalable imaging technology for high-resolution, quantitative, and collaborative insights
Precise imaging data-analysis platforms for dependable, concise, and efficient results
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Connor Gilbert
Partnerships Director